Skip to main content
. 2023 Jun 21;15(6):e40742. doi: 10.7759/cureus.40742

Table 1. Examples of cytokines-armed OVs, mechanism of action, and cancer types in clinical trials.

MOA: mechanism of action, OV: oncolytic virus, IL-12: interleukin-12, NK: natural killer cells, HSV: herpes simplex virus, TNBC: triple-negative breast cancer, GM-CSF: granulocyte-macrophage colony-stimulating factor, DCs: dendritic cells, GIT: gastrointestinal, IFN-B: interferon beta, VSV: vesicular stomatitis virus, HCC: hepatocellular cell carcinoma, AML: acute myeloid leukemia.

Cytokines MOA Virus Family OV variants Cancer type
IL-12 [11] NK and T cells activation. Antiangiogenic. HSV M032 Glioblastoma, astrocytoma, gliosarcoma
ONCR-177 Solid tumors
Vaccinia TBio-6517 Colorectal cancer, TNBC
GM-CSF [12]   Activation of DCs Adenovirus ONCOS-102 Melanoma
HSV T-VEC Melanoma, non-melanoma skin cancer, breast cancer, GIT tumors, ovarian cancer
Paramyxovirus MED15395 Solid tumors.
Vaccinia Pexa-vec Renal cell carcinoma, HCC.
IFN-B [13] Promote apoptosis, antiangiogenetic, enhance tumor antigenicity [12] Vesicular stomatitis virus VSV-IFNB+ HCC
VSV-hIFNbeta-NIS [14] T-cell lymphoma, AML, multiple myeloma.